PDK4 and neoplasm: Clinically, a positive correlation was detected between PDK4 immunoreactivity and advanced tumour stages, grades and serous histological subtypes, as well as metastasis, highlighting a potential role of PDK4 in ovarian cancer progression and aggressiveness.